Following the pre-clinical observation that IKKα activation by RANKL was correlated with metastatic progression of PCa and tumor infiltration with RANKL-expressing inflammatory cells [126], the HER2-induced mammary carcinogenesis model was subsequently used to address RANKL nature [127]. The gene discussed is TNFSF11; the disease is neoplasm.